Venetoclax-based low intensity therapy in molecular failure of NPM1 mutated AML

Richard Dillon

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Venetoclax-based low intensity therapy in molecular failure of NPM1 mutated AML'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science